These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7758924)

  • 1. Tetracycline effect on osteoclastic and osteoblastic activity.
    Keller DC; Carano A
    Gen Dent; 1995; 43(1):60-3. PubMed ID: 7758924
    [No Abstract]   [Full Text] [Related]  

  • 2. Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro.
    Huang J; Yuan L; Wang X; Zhang TL; Wang K
    Life Sci; 2007 Aug; 81(10):832-40. PubMed ID: 17764702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPAR gamma: ally and foe in bone metabolism.
    Wahli W
    Cell Metab; 2008 Mar; 7(3):188-90. PubMed ID: 18316021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone temporal effects on bone formation and resorption.
    Kroll MH
    Bull Math Biol; 2000 Jan; 62(1):163-88. PubMed ID: 10824426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [TSH affects bone metabolism. Surprising skeletal changes in genetically modified mice].
    Lindstedt G
    Lakartidningen; 2004 Feb; 101(6):476-7. PubMed ID: 15004943
    [No Abstract]   [Full Text] [Related]  

  • 7. Osteoblast-like cells complete osteoclastic bone resorption and form new mineralized bone matrix in vitro.
    Mulari MT; Qu Q; Härkönen PL; Väänänen HK
    Calcif Tissue Int; 2004 Sep; 75(3):253-61. PubMed ID: 15148559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minocycline impairment of both osteoid tissue removal and osteoclastic resorption in a synchronized model of remodeling in the rat.
    Klapisz-Wolikow M; Saffar JL
    J Cell Physiol; 1996 May; 167(2):359-68. PubMed ID: 8613479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen stimulates the elaboration of cell/matrix surface-associated inhibitory factor of osteoclastic bone resorption from osteoblastic cells.
    Ishii T; Saito T; Morimoto K; Takeuchi Y; Asano S; Kumegawa M; Ogata E; Matsumoto T
    Biochem Biophys Res Commun; 1993 Mar; 191(2):495-502. PubMed ID: 8461006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a traditional Chinese herbal preparation on osteoblasts and osteoclasts.
    Zhang H; Xing WW; Li YS; Zhu Z; Wu JZ; Zhang QY; Zhang W; Qin LP
    Maturitas; 2008 Dec; 61(4):334-9. PubMed ID: 19004583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
    Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
    Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The majority of osteoclasts require mRNA and protein synthesis for bone resorption in vitro.
    Hall TJ; Schaeublin M; Chambers TJ
    Biochem Biophys Res Commun; 1993 Sep; 195(3):1245-53. PubMed ID: 8216256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience of vitamin K2 in Thailand].
    Bunyaratavej N
    Clin Calcium; 2007 Nov; 17(11):1752-60. PubMed ID: 17982197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa lipopolysaccharide induces osteoclastogenesis through a toll-like receptor 4 mediated pathway in vitro and in vivo.
    Zhuang L; Jung JY; Wang EW; Houlihan P; Ramos L; Pashia M; Chole RA
    Laryngoscope; 2007 May; 117(5):841-7. PubMed ID: 17473680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts.
    Woo JT; Kawatani M; Kato M; Shinki T; Yonezawa T; Kanoh N; Nakagawa H; Takami M; Lee KH; Stern PH; Nagai K; Osada H
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4729-34. PubMed ID: 16537392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel bromomelatonin derivatives suppress osteoclastic activity and increase osteoblastic activity: implications for the treatment of bone diseases.
    Suzuki N; Somei M; Kitamura K; Reiter RJ; Hattori A
    J Pineal Res; 2008 Apr; 44(3):326-34. PubMed ID: 18339128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.
    Löwik CW; Nibbering PH; van de Ruit M; Papapoulos SE
    J Clin Invest; 1994 Apr; 93(4):1465-72. PubMed ID: 8163651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of enamel matrix derivative on gene expression in osteoblasts.
    Reseland JE; Reppe S; Larsen AM; Berner HS; Reinholt FP; Gautvik KM; Slaby I; Lyngstadaas SP
    Eur J Oral Sci; 2006 May; 114 Suppl 1():205-11; discussion 254-6, 381-2. PubMed ID: 16674687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells.
    Jimi E; Nakamura I; Duong LT; Ikebe T; Takahashi N; Rodan GA; Suda T
    Exp Cell Res; 1999 Feb; 247(1):84-93. PubMed ID: 10047450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Osteoclast function is regulated by neighbouring osteoblasts. Osteoprotegerin, RAND and RANK ligand constitute a unique regulatory system for bone resorption with important pathophysiological and therapeutic aspects].
    Ueland T; Bollerslev J; Mosekilde L
    Ugeskr Laeger; 2002 Jul; 164(27):3526-30. PubMed ID: 12116680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.